Introduction About GERBISA L SOLUTION

GERBISA L SOLUTION contains Sodium picosulfate which belongs to the group of medicines called Laxatives. It is used for short-term relief of functional constipation. Constipation is defined as fewer than three bowel movements a week, stools that are hard, dry, lumpy, difficult, or painful to pass.

Your doctor might advise you to take a rich fibre diet, have more fluid intake, and do regular exercise. GERBISA L SOLUTION is not recommended for use in patients with severe dehydration, ileus, gastrointestinal obstruction, gastrointestinal ulceration, or perforation.

Avoid the consumption of alcohol during management with this medicine. It is also not recommended if you have appendicitis, acute inflammatory bowel diseases, or severe abdominal pain associated with nausea and vomiting.

GERBISA L SOLUTION should be used with caution in patients with liver disease or epilepsy. It should be used with caution in pregnant and breastfeeding women. GERBISA L SOLUTION is not recommended for use in children under 12 years of age.

GERBISA L SOLUTION should be used with caution in elderly patients. The most common side effects of taking GERBISA L SOLUTION are diarrhoea, abdominal pain, cramps, or discomfort. Do consult your physician if any of the side effects worsen.

Uses Of GERBISA L SOLUTION

• Used to manage short-term relief of functional constipation

How GERBISA L SOLUTION Works

GERBISA L SOLUTION works by increasing the mucosa of the large intestine and rectum. Which in turn increases its motility (movement), accumulation of water, hence softening the stool and stimulating defecation (emptying of the bowel).

How to use GERBISA L SOLUTION

Take GERBISA L SOLUTION as advised by your doctor. Shake well before use. Your doctor will decide the correct dose and duration of medicine depending upon your age, body weight and disease condition. Do not exceed the recommended dosage.

Side Effects Of GERBISA L SOLUTION

How To Manage Side Effects

Stomach pain:

Try to rest and relax. Eat small meals but take them frequently. Keep a heating pad on your stomach. Contact your doctor if the stomach pain doesn’t improve.

Diarrhoea:

Drink plenty of water or fruit juices to keep yourself hydrated. Don’t take any medicine on your own for managing diarrhoea. Contact your doctor if diarrhoea worsens.

Warning & Precautions

Pregnancy

GERBISA L SOLUTION should be used with caution in pregnancy or women planning to have a baby unless. Contact your doctor before taking it.

Breastfeeding

GERBISA L SOLUTION should be used with caution in breastfeeding women. Contact your doctor before taking GERBISA L SOLUTION.

Driving and Using Machines

Do not drive or use machines while taking GERBISA L SOLUTION as you may feel dizzy. Consult your doctor for advice.

Alcohol

Avoid consumption of alcohol while taking GERBISA L SOLUTION.

Liver

GERBISA L SOLUTION should be used with caution in patients with liver disease. Contact your doctor before taking.

Allergy

Do not take GERBISA L SOLUTION if you are allergic to Sodium picosulfate or any other ingredients of this medicine.

Interactions

A. Drug-Drug Interactions:

Before taking GERBISA L SOLUTION, inform your doctor if you are taking any of the following medicine:

• diuretics (medicines used to increase urine output) Ex. bendrofluazide, furosemide
• corticosteroids (medicines used to manage inflammatory conditions) Ex. prednisolone
• cardiac glycosides (used to manage heart disorders) Ex. digoxin
• antibiotics (used to manage infections) Ex. amoxicillin

Overdosage:

If you or anyone else accidentally take too much of GERBISA L SOLUTION, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are diarrhea, abdominal cramps and a clinically significant loss of potassium and other electrolytes.

Synopsis

More Information

• Keep GERBISA L SOLUTION out of sight and reach of children
• Store GERBISA L SOLUTION at room temperature

FAQs About GERBISA L SOLUTION

Q: What is GERBISA L SOLUTION used for?

A: GERBISA L SOLUTION is used for short-term relief of functional constipation in adults and children above 12 years of age. Contact your doctor for more information before taking it.

Q: Does GERBISA L SOLUTION help with weight loss?

A: Stimulant laxatives, including GERBISA L SOLUTION do not help with weight loss. These medicines do not reduce the absorption of calories or nutrients. They may cause watery stools (diarrhoea), abdominal cramps and dehydration. Dehydration may seem like weight loss.

Q: What does constipation mean and why does it happen?

A: Constipation is a bowel disorder that occurs due to the slowing down of the muscle actions in the large intestine. It may be caused due to a sudden change of diet, a less fibrous diet, loss of muscle tone in elderly people, pregnancy, certain medicines (morphine or codeine), prolonged bedtime and lack of exercise. The symptoms of constipation include bloating, discomfort or sometimes headache.

Q: What are the natural ways to manage constipation?

A: Constipation may be relieved by certain lifestyle and diet modifications such as: Eating a balanced diet including fresh fruit and vegetables, drinking enough water so that you do not become dehydrated and exercising to stay fit.

Q: How does GERBISA L SOLUTION help in relieving constipation?

A: GERBISA L SOLUTION works by increasing the mucosa of the large intestine and rectum. Which in turn increases its motility (movement), accumulation of water, hence softening the stool and stimulating defecation (emptying of the bowel).

References

1. KD. Tripathi. Gastrointestinal drugs. Essentials of medical pharmacology. Eighth Edition. 2019. Page – 724.

2. Stefan Mueller-Lissner, Michael A Kamm, Arnold Wald, Ulrika Hinkel, Ursula Koehler, Erika Richter, Jurgen Bubeck. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. April 2010. [Accessed on 30th June 2022] https://pubmed.ncbi.nlm.nih.gov/20179697/

3. Meredith Portalatin and Nathaniel Winstead. Medical Management of Constipation. NIH National Library of Medicine. National Centre for Biotechnology Information.
PMC. Pubmed Central. March 2012. [Accessed on 30th June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348737/

4. Sanofi. Electronic Medicines Compendium (EMC). [Revised in August 2020] [Accessed on 30th June 2022] https://www.medicines.org.uk/emc/files/pil.905.pdf, https://www.medicines.org.uk/emc/product/905/smpc

5. Opella Healthcare France SAS T/A Sanofi. Health Products Regulatory Authority (HPRA). [Revised in October 2021] [Accessed on 30th June 2022] https://www.hpra.ie/img/uploaded/swedocuments/Licence_PA23180-017-001_29102021165505.pdf